NeoGenomics expands its NGS portfolio with the launch of Neo Comprehensive(TM) – Solid Tumor CGP and Neo Comprehensive(TM) – Myeloid Disorders CGP
-
Portfolio
NeoGenomics expands its NGS portfolio with the launch of Neo Comprehensive(TM) – Solid Tumor CGP and Neo Comprehensive(TM) – Myeloid Disorders CGP
FT. MYERS, FL / ACCESSWIRE / March 13, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and…
Read More »